Dobutamine Pregnancy and Breastfeeding Warnings
Dobutamine is also known as: Dobutrex
Dobutamine Pregnancy Warnings
There is only one case report of the use of dobutamine during the second trimester in a 41-year-old woman who suffered an inferior wall myocardial infarction and cardiac arrest. The woman subsequently delivered at 38 weeks gestation. The female infant's weight and head circumference were at the greater than 50th and greater than 10th percentile, respectively. Apgar scores were 6 and 8 at 1 and 5 minutes, respectively. No abnormality was discovered in the initial assessment. By age 17 months all normal landmarks were passed, but the child's weight and height were inexplicably below the 10th percentile.
Dobutamine has been assigned to pregnancy category B by the FDA. Animal studies have revealed no evidence of impaired fertility, harm to the fetus, or teratogenic effects associated with dobutamine. There are no controlled data in human pregnancy. Dobutamine should be given during pregnancy when need has been clearly established.
Dobutamine Breastfeeding Warnings
There are no data on the excretion of dobutamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
- Dobutamine use while Breastfeeding (in more detail)
- dobutamine Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.